Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ASP Isotopes (ASPI) Operating Expenses (2022 - 2025)

ASP Isotopes has reported Operating Expenses over the past 4 years, most recently at $27.1 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 228.39% year-over-year to $27.1 million; the TTM value through Dec 2025 reached $63.3 million, up 126.5%, while the annual FY2025 figure was $63.3 million, 126.5% up from the prior year.
  • Operating Expenses for Q4 2025 was $27.1 million at ASP Isotopes, up from $15.4 million in the prior quarter.
  • Over five years, Operating Expenses peaked at $27.1 million in Q4 2025 and troughed at $827959.0 in Q2 2022.
  • A 4-year average of $7.0 million and a median of $5.0 million in 2023 define the central range for Operating Expenses.
  • Biggest five-year swings in Operating Expenses: surged 425.09% in 2023 and later skyrocketed 35.86% in 2025.
  • Year by year, Operating Expenses stood at $1.5 million in 2022, then surged by 185.26% to $4.2 million in 2023, then soared by 98.3% to $8.3 million in 2024, then surged by 228.39% to $27.1 million in 2025.
  • Business Quant data shows Operating Expenses for ASPI at $27.1 million in Q4 2025, $15.4 million in Q3 2025, and $12.5 million in Q2 2025.